UrgoStart Logo UrgoStart Campaign Cover
 
 
 
 
 
Find out how UrgoStart can help you reduce the healing time of chronic wounds by 100 Days* (1)
 
 twitter logoFacebook Logo
 
 
#Save100Days 
 
 
 
 UrgoStart LogoUrgoStart Contact LogoUrgoStart Border Logo
 

PATIENTS WITH WOUNDS SUFFER EVERY DAY FROM A DECREASED QUALITY OF LIFE

The emotional and physical impact of wounds, especially chronic wounds such as venous leg ulcers, pressure ulcers and diabetic foot ulcers is huge, and can be life changing (2)(3)

 

 THE BURDEN OF CHRONIC WOUNDS IS HIGH FOR THE NHS (4) (5)

 

Burden on NHS
 

 

WHY DO CHRONIC WOUNDS NOT HEAL AS FAST AS ACUTE WOUNDS?

 

  
Arrows UrgoStart
 
Arrows UrgoStart
 
Arrows UrgoStart
 Chronic Wounds

Some wounds are known to be chronic by nature e.g. venous leg ulcers, pressure ulcers, diabetic foot ulcers 

 Often get 'stuck' in the inflammation stage of healing so the process cannot complete.

 During the inflammation stage, enzymes known as proteases are released to break down damaged tissue in both acute and chronic wounds; an essential part of the healing process.

In acute wounds, the protease levels are controlled, but in chronic wounds, there is an elevated and prolonged expression.(6) 

Excess proteases break down newly formed healthy tissue and so impede healing.(6) 
 Acute Wounds

Result of surgery or trauma e.g. knife wound, accident 

 Usually show signs of healing within 4 weeksfollowing:
 1. Haemostasis (clotting)

2. Inflammation

3. Proliferation

4. Maturation

 Healing

 

CHOOSING THE RIGHT DRESSING IMPROVES THE HEALING OUTCOME OF CHRONIC WOUNDS  

 

Table Protease inhibitor


The right choice of dressing can:

  • Improve condition of the wound bed and surrounding tissue
  • Reduce both the pain and stress of dressing changes
  • Improve healing rates

Healing wounds faster helps clinicians to: 

  • Improve quality of life
  • Bring an earlier return to normality for patients
  • Avoid complications, such as infection and amputation
  • Minimise overall treatment costs
  • Improve the patient experience 
 
 
 
 

 URGOSTART: GIVING YOUR PATIENTS THE POTENTIAL FOR AN EXTRA 100 DAYS WOUND FREE

Average days to closure

 

New real-life data is available, observed in over 10,000 patients treated with UrgoStart (1):

 

  • • UrgoStart reduces healing time of leg ulcers and pressure ulcers by an average of 100 days (the average time to closure is similar in diabetic foot ulcers)
  • • Efficacy observed in real-life with over 10,000 patients is consistent with RCT results (7)

 

 

 

 

 

 

URGOSTART PROVIDES A COMFORTABLE EXPERIENCE FOR PATIENTS 

 

Percentage UrgoStart

 

 

 

 

 

 "Nurses try this & that... every week a new dressing, nothing gets chance to work, the pain just persists"

 Patient description of wound care

 

 

 Discover the UrgoStart range

UrgoStart Logo
UrgoStart Contact Logo
UrgoStart Border Logo

 

 Read posters


 

poster 5

An 8-week open-label, non-comparative, multicentre evaluation of the performance of a Technology Lipido-Colloid Nano-Oligosaccharide Factor wound dressing

 

eposter 7

Clinical evaluation of UrgoStart wound dressings in ‘hard to heal’ diabetic foot ulcers.
 

 

eposter 11

The Use of a protease inhibitor dressing in combination with negative pressure wound therapy

 

eposter 14

Developing and Implementing a Leg Ulcer Pathway to Improve Wound Healing Outcomes


*Real-life data in over 10,000 patients: healing time reduction observed for leg ulcers and pressure ulcers. The average time to closure is similar in diabetic foot ulcers.

 References:

(1)  Münter KC, Meaume S, Augustin M, Senet P, Kérihuel J.C. The reality of routine practice: a pooled data analysis on chronic wounds treated with TLC-NOSF wound dressings. Journal of Wound Care 2017; 26: WUWHS Suppl, S4–S15.
(2) Upton D. Wounds UK. 2013;9(2):83;

(3) Leonard S, et al. Nurs Times. 2009;105(16):38-9.

(4)Guest JF, et al. Int J J 2016 doi: 10.1111/iwj.12603;

(5) Guest JF, et al. BMJ Open 2015;5:009283. doi: 10.1136/bmjopen-2015-009283

(6) Raffetto J.D. Phlebology 2014;29(Suppl 1):157–64.

(7) Meaume et al. Wound Repair Regen 2012; 20: 4, 500–511.

(8) Average days to closure data from the SNIIRAM French national database. French Health Insurance Report to the Ministry of Health for 2014. July 2013. 

(9) Münter, K-C. [UrgoCell Start Anwendungsergebnisse aus ambulanten Einrichtungen.] [Article in German] Medizin & Praxis Spezial: Wundheilungsstörungen,2008, 6–9;

 (10) Tsantilas et al. EWMA, Madrid, 2014. Poster 49476.